In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry.
about
Calcineurin signaling and membrane lipid homeostasis regulates iron mediated multidrug resistance mechanisms in Candida albicansComparative lipidomics in clinical isolates of Candida albicans reveal crosstalk between mitochondria, cell wall integrity and azole resistanceProteomic analysis of Rta2p-dependent raft-association of detergent-resistant membranes in Candida albicansExtra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatuscDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol.Propofol lipidic infusion promotes resistance to antifungals by reducing drug input into the fungal cellComparative lipidomics of azole sensitive and resistant clinical isolates of Candida albicans reveals unexpected diversity in molecular lipid imprints.Functional analysis of CaIPT1, a sphingolipid biosynthetic gene involved in multidrug resistance and morphogenesis of Candida albicans.UPC2A is required for high-level azole antifungal resistance in Candida glabrata.Update on terbinafine with a focus on dermatophytosesGenome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates.Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterolsTriclosan antagonizes fluconazole activity against Candida albicans.Synergistic antifungal activity of berberine derivative B-7b and fluconazole.In vitro effect of malachite green on Candida albicans involves multiple pathways and transcriptional regulators UPC2 and STP2.Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformans.An update on antifungal targets and mechanisms of resistance in Candida albicans.The non-Geldanamycin Hsp90 inhibitors enhanced the antifungal activity of fluconazole.Lipidomics and in vitro azole resistance in Candida albicans.Fluconazole assists berberine to kill fluconazole-resistant Candida albicans.Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans.Novel Regulatory Mechanisms of Pathogenicity and Virulence to Combat MDR in Candida albicans.Analysis of sphingolipids, sterols and phospholipids in human pathogenic Cryptococcus strains.Plasma membrane lipids and their role in fungal virulence.Antifungals: Mechanism of Action and Drug Resistance.Unexpected link between iron and drug resistance of Candida spp.: iron depletion enhances membrane fluidity and drug diffusion, leading to drug-susceptible cells.Drug susceptibilities of yeast cells are affected by membrane lipid composition.ABC transporters and azole susceptibility in laboratory strains of the wheat pathogen Mycosphaerella graminicola.Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters.Multidrug transporters CaCdr1p and CaMdr1p of Candida albicans display different lipid specificities: both ergosterol and sphingolipids are essential for targeting of CaCdr1p to membrane rafts.Membrane fluidity and lipid composition of fluconazole resistant and susceptible strains of Candida albicans isolated from diabetic patients.Membrane rafts are involved in intracellular miconazole accumulation in yeast cells.Antifungal activity of α-methyl trans cinnamaldehyde, its ligand and metal complexes: promising growth and ergosterol inhibitors.Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms.A key structural domain of the Candida albicans Mdr1 protein.Potent In Vitro Synergism of Fluconazole and Osthole against Fluconazole-Resistant Candida albicans.Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant Candida albicans Isolates.Azole resistance in a Candida albicans mutant lacking the ABC transporter CDR6/ROA1 depends on TOR signaling.Synergistic antifungal indolecarbazoles from Streptomyces sp. CNS-42 associated with traditional Chinese medicine Alisma orientale.Inhibition of Candida albicans virulence factors by novel levofloxacin derivatives.
P2860
Q28477740-2441D35C-646F-47C7-9245-40EB0A4C9718Q28480747-89C9F8EC-5D52-49CF-9C24-63CA37B111BDQ28483932-D545854B-7492-4FE9-8229-491AA1C3333AQ30764085-27ACDFF3-2540-49BB-8ECE-715EA385ECC2Q31143838-1B820AD6-DDA0-48D5-8D6A-9DE04D1E33ADQ33315163-AF947DF7-756A-4127-A000-DEFA7AD0B253Q33894971-DBE681F1-8924-4311-A893-289D4F2DF9C3Q33937992-5A452DF9-EC7E-463B-B2FE-DFEBBF5F9BD0Q34058180-07FA3A8B-70B6-4D15-A27B-EAB0478B3217Q34620230-0FFBC63D-4016-465B-B721-46E34548B9D2Q34887876-5A524730-A341-4680-B7A0-DE14A1834296Q35164903-9E97BDD1-8F01-47DC-A25C-26A5DF3F738DQ35596548-9B1F2A04-FF04-4AEF-91A7-2CDD5319FA99Q35625551-3E6968EB-6210-4B08-85C3-8B59C589D8AAQ35666568-8B23DB31-D7E8-47EC-B4FF-5BAB6A963575Q35854764-3F30BDCC-BC64-4EEB-8916-9A0E12AF1B5AQ36235037-EA8DDE85-10DA-499C-96F0-EC4927F80B54Q36516675-2F114A95-04B4-4045-A3F0-946AA9FC7383Q36596097-9989039B-4FAE-4B39-B5C9-87BCDB3A2D04Q37335827-C12F90A1-2A1B-479A-B572-1D6962176F45Q37734737-083151DB-8D21-430B-B4E2-4B5E5B83CA76Q38155848-89308432-608F-4DC2-A2F3-4FEBDDFDD6BBQ38623199-F7143C9A-FEB1-4DDB-9896-11831550C1B4Q38679057-99CC8BAF-31FD-4B59-B907-D0562906B27EQ38684281-36DF9EF7-C088-4618-BFDD-5669EBD45D08Q39077878-7A13C0E0-5361-42A7-97B7-A59DF270EF92Q39671060-6D40A2D9-3784-4C8B-A508-E2805E35D891Q39671157-E208FD83-4F10-4DF9-AE55-2436039CFBD3Q39746465-6DE3128C-0D75-4C9A-A4FF-72BCB14A0E82Q41915187-E268FAD8-488D-4C4E-9BC4-3020BBF41ABBQ41943919-DD484E5F-84D5-4C35-8CA7-5BBC4953EBE9Q42662001-14CDE93F-72F8-4911-A2E3-E91D8C6ED9ADQ42743451-E9F8FBC8-1413-4B71-BF0C-60A0CF96F26AQ43063852-111B0714-388A-4656-998D-2100EC16CBB5Q43551296-B19637C3-216F-49E8-B866-40203B81E2F4Q46352192-E4E0B8BC-477E-4074-B1F2-C798F527EFC1Q47107191-6A610872-0972-4F0C-A3D0-02A62E9983A6Q47329636-8DB4751F-AD24-48DB-B33A-4C29141BE447Q51051298-6E7DD662-1FCC-4125-8454-E33B09EC9A30Q51742354-7E847429-2F94-4119-8645-7C1A60268CF9
P2860
In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
In vitro low-level resistance ...... lipid fluidity and asymmetry.
@en
In vitro low-level resistance ...... lipid fluidity and asymmetry.
@nl
type
label
In vitro low-level resistance ...... lipid fluidity and asymmetry.
@en
In vitro low-level resistance ...... lipid fluidity and asymmetry.
@nl
prefLabel
In vitro low-level resistance ...... lipid fluidity and asymmetry.
@en
In vitro low-level resistance ...... lipid fluidity and asymmetry.
@nl
P2093
P2860
P1476
In vitro low-level resistance ...... lipid fluidity and asymmetry.
@en
P2093
Ashok Rattan
Avmeet Kohli
Kasturi Mukhopadhyay
Rajendra Prasad
P2860
P304
P356
10.1128/AAC.46.4.1046-1052.2002
P407
P577
2002-04-01T00:00:00Z